[Pharmacological properties and clinical use of xanthinol nicotinate].
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D002415:Cats; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D051379:Mice; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D051381:Rats; D011928:Raynaud Disease / Q000188:drug therapy; D013806:Theophylline / Q000031:analogs & derivatives*; D014971:Xanthinol Niacinate / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D014971:Xanthinol Niacinate; D013806:Theophylline
Farmakologicheskie svoĭstva i klinicheskoe primenenie ksantinola nikotinata.